300006 莱美药业
午间休市 08-21 11:30:00
资讯
新帖
简况
图解莱美药业中报:第二季度单季净利润同比增长52.25%
证券之星 · 01:15
图解莱美药业中报:第二季度单季净利润同比增长52.25%
莱美药业(300006)7月31日股东户数2.54万户,较上期增加6.47%
证券之星 · 08-20 17:37
莱美药业(300006)7月31日股东户数2.54万户,较上期增加6.47%
Moderna癌症疫苗三期成功 创新药、疫苗板块大幅高开 莱美药业等一字涨停
中金财经 · 08-20 10:04
Moderna癌症疫苗三期成功 创新药、疫苗板块大幅高开 莱美药业等一字涨停
生物疫苗股全线大涨,康希诺等5股20CM涨停,默沙东莫德纳黑色素瘤疫苗临床试验传捷报
格隆汇 · 08-20 09:47
生物疫苗股全线大涨,康希诺等5股20CM涨停,默沙东莫德纳黑色素瘤疫苗临床试验传捷报
莱美药业(300006)7月31日股东户数2.54万户,较上期增加6.47%
证券之星 · 08-10
莱美药业(300006)7月31日股东户数2.54万户,较上期增加6.47%
莱美药业(300006.SZ)获得吸入用乙酰半胱氨酸溶液药品注册证书
智通财经 · 08-10
莱美药业(300006.SZ)获得吸入用乙酰半胱氨酸溶液药品注册证书
莱美药业:截至2026年7月31日,公司股东户数为25,384
证券之星 · 08-10
莱美药业:截至2026年7月31日,公司股东户数为25,384
莱美药业(300006)7月20日股东户数2.38万户,较上期减少2.57%
证券之星 · 07-27
莱美药业(300006)7月20日股东户数2.38万户,较上期减少2.57%
莱美药业(300006)披露签署《药品上市许可转让协议》公告,7月23日股价下跌4.55%
证券之星 · 07-23
莱美药业(300006)披露签署《药品上市许可转让协议》公告,7月23日股价下跌4.55%
莱美药业(300006.SZ)与天之海药业签署关于维生素D₂软胶囊药品上市许可转让协议
智通财经网 · 07-23
莱美药业(300006.SZ)与天之海药业签署关于维生素D₂软胶囊药品上市许可转让协议
股市必读:莱美药业(300006)股东户数2.45万户,较上期减少1.05%
证券之星 · 07-20
股市必读:莱美药业(300006)股东户数2.45万户,较上期减少1.05%
莱美药业(300006)7月10日股东户数2.45万户,较上期减少1.05%
证券之星 · 07-17
莱美药业(300006)7月10日股东户数2.45万户,较上期减少1.05%
莱美药业:截至2026年4月30日,公司股东户数为24,889
证券之星 · 07-17
莱美药业:截至2026年4月30日,公司股东户数为24,889
股市必读:莱美药业(300006)股东户数2.47万户,较上期增加3.39%
证券之星 · 07-15
股市必读:莱美药业(300006)股东户数2.47万户,较上期增加3.39%
莱美药业:截至2026年6月18日,公司股东户数为23,919
证券之星 · 07-14
莱美药业:截至2026年6月18日,公司股东户数为23,919
莱美药业:纳米炭铁混悬注射液联合放疗已正式进入二期临床阶段
证券之星 · 07-14
莱美药业:纳米炭铁混悬注射液联合放疗已正式进入二期临床阶段
莱美药业:严格控制成本费用,实现可控费用持续下降
证券之星 · 07-14
莱美药业:严格控制成本费用,实现可控费用持续下降
莱美药业(300006)6月30日股东户数2.47万户,较上期增加2.73%
证券之星 · 07-06
莱美药业(300006)6月30日股东户数2.47万户,较上期增加2.73%
莱美药业(300006)披露产业投资基金拟清算注销公告,7月2日股价下跌3.87%
证券之星 · 07-02
莱美药业(300006)披露产业投资基金拟清算注销公告,7月2日股价下跌3.87%
股市必读:莱美药业(300006)6月15日董秘有最新回复
证券之星 · 06-16
股市必读:莱美药业(300006)6月15日董秘有最新回复
加载更多
公司概况
公司名称:
重庆莱美药业股份有限公司
所属行业:
医药制造业
上市日期:
2009-10-30
主营业务:
重庆莱美药业股份有限公司的主营业务是医药制造。公司的主要产品是特色专科类化药(包括抗肿瘤药、消化系统药、肠外营养药)、抗感染类化药。公司2019年被工信部认定为“国家技术创新示范企业”,荣获“新中国成立70年医药产业标杆企业”,2021年被重庆市经信委评为重庆市工业和信息化重点实验室,2022年被国家知识产权局评为“国家知识产权示范企业”,2024年被制造业跃升领导小组办公室评为“制造业跃升发展创新领军企业”,2025年被南岸区重庆经开区制造业高质量发展办公室评为“制造业创新领军企业”,2026年被全联药业商会评为2025-2026年度医药行业自主创新企业。
发行价格:
16.50
{"stockData":{"symbol":"300006","market":"SZ","secType":"STK","nameCN":"莱美药业","latestPrice":5.39,"timestamp":1787286660000,"preClose":5.94,"halted":0,"volume":107802568,"delay":0,"changeRate":-0.0926,"floatShares":1056000000,"shares":1056000000,"eps":-0.1201,"marketStatus":"午间休市","change":-0.55,"latestTime":"08-21 11:30:00","open":5.64,"high":5.82,"low":5.15,"amount":586000000,"amplitude":0.1128,"askPrice":5.39,"askSize":1062,"bidPrice":5.38,"bidSize":661,"shortable":0,"etf":0,"ttmEps":-0.1201,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787288400000},"marketStatusCode":3,"adr":0,"adjPreClose":5.94,"symbolType":"stock","openAndCloseTimeList":[[1787275800000,1787283000000],[1787288400000,1787295600000]],"highLimit":6.53,"lowLimit":5.35,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1055911205,"isCdr":false,"pbRate":3.6,"roa":"--","roe":"--","epsLYR":-0.1276,"committee":0.39348,"marketValue":5691000000,"turnoverRate":0.1021,"status":1,"floatMarketCap":5691000000},"requestUrl":"/m/hq/s/300006","defaultTab":"news","newsList":[{"id":"2661398932","title":"图解莱美药业中报:第二季度单季净利润同比增长52.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661398932","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661398932?lang=zh_cn&edition=full","pubTime":"2026-08-21 01:15","pubTimestamp":1787246110,"startTime":"0","endTime":"0","summary":"证券之星消息,莱美药业2026年中报显示,上半年度公司主营收入3.5亿元,同比下降7.09%;归母净利润-2341.75万元,同比上升25.37%;扣非净利润-2577.49万元,同比上升20.04%;其中2026年第二季度,公司单季度主营收入1.68亿元,同比下降5.91%;单季度归母净利润-840.48万元,同比上升52.25%;单季度扣非净利润-1030.46万元,同比上升42.57%;负债率35.96%,投资收益-1856.66万元,财务费用-411.48万元,毛利率51.9%。财报数据概要请见下图:本文数据来源于莱美药业2026年中报,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100001084.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300006"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660888632","title":"莱美药业(300006)7月31日股东户数2.54万户,较上期增加6.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660888632","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660888632?lang=zh_cn&edition=full","pubTime":"2026-08-20 17:37","pubTimestamp":1787218662,"startTime":"0","endTime":"0","summary":"证券之星消息,近日莱美药业披露,截至2026年7月31日公司股东户数为2.54万户,较7月20日增加1542.0户,增幅为6.47%。在化学制药行业个股中,莱美药业股东户数低于行业平均水平,截至7月31日,化学制药行业平均股东户数为3.7万户。从股价来看,2026年7月20日至2026年7月31日,莱美药业区间涨幅为6.1%,在此期间股东户数增加1542.0户,增幅为6.47%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000031810.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300006","BK0239","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660778834","title":"Moderna癌症疫苗三期成功 创新药、疫苗板块大幅高开 莱美药业等一字涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2660778834","media":"中金财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660778834?lang=zh_cn&edition=full","pubTime":"2026-08-20 10:04","pubTimestamp":1787191443,"startTime":"0","endTime":"0","summary":"Moderna癌症疫苗三期成功 创新药、疫苗板块大幅高开 莱美药业等一字涨停 分时图\r\n\r\n 8月20日消息,早盘创新药、疫苗板块大幅高开,莱美药业、沃森生物、康希诺、键凯科技、悦康药业、双鹭药业、百克生物等一字涨停,智飞生物、石药创新、康泰生物等涨超10%。\r\n\r\n 消息面上,隔夜美股莫德纳股价大涨近180%。默沙东与莫德纳周三宣布,双方合作的 mRNA 个性化癌症疫苗 intismeran autogene 首个 III 期临床试验取得初步阳性结果。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202608/20/20260820203988.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202608/20/20260820203988.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/shichangceping/20260820/32340703.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["159646","BK1161","BK0070","159992","BK0239","06978","IBBQ","MEDX","300006","LNGR","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660727484","title":"生物疫苗股全线大涨,康希诺等5股20CM涨停,默沙东莫德纳黑色素瘤疫苗临床试验传捷报","url":"https://stock-news.laohu8.com/highlight/detail?id=2660727484","media":"格隆汇","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660727484?lang=zh_cn&edition=full","pubTime":"2026-08-20 09:47","pubTimestamp":1787190439,"startTime":"0","endTime":"0","summary":"8月20日,A股市场生物疫苗股全线大涨,其中,百克生物、康希诺、沃森生物、莱美药业、智飞生物20CM涨停,康华生物逼近20CM涨停,康泰生物涨超17%,华兰疫苗涨超10%,德展健康、双鹭药业、海普瑞、海欣股份、万泰生物10CM涨停,金迪克、博晖创新涨超7%,西藏药业、卫光生物、利德曼、冠昊生物、塞力医疗、赛升药业、申联生物、欧林生物涨超6%。消息面上,默沙东与莫德纳周三宣布,联合研发的黑色素瘤皮肤癌疫苗在首次晚期临床试验中取得积极初步结果。\n\n港股频道更多独家策划、专家专栏,免费查阅>>\n\n 责任编辑:栎树","market":"hk","thumbnail":"http://imgcloud.jrjimg.cn/2026/08/cms_20260820094719181.jpg","type":0,"news_type":0,"thumbnails":["http://imgcloud.jrjimg.cn/2026/08/cms_20260820094719181.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/08/20094758182842.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["IE00BLSP4239.USD","688185","IE0009355771.USD","LU0689626769.HKD","LU2491050071.SGD","BK4501","LU2023250843.SGD","LU0098860793.USD","301207","LU0861579265.USD","LU0942090050.USD","LU1989772840.SGD","XLV","LU0130102774.USD","LU1571399168.USD","LU1023059063.AUD","BK0077","IE00BJJMRZ35.SGD","LU0211331839.USD","LU1989771016.USD","LU1585245621.USD","LU0868494617.USD","LU0965509283.SGD","BK4550","LU0234572021.USD","LU0965508806.USD","LU2023250504.SGD","LU1066051498.USD","SG9999001440.SGD","LU1064131003.USD","LU2125909593.SGD","LU1291159041.SGD","LU1941712348.USD","LU2361044865.SGD","IE00BN8TJ469.HKD","LU0124676726.USD","VHT","LU1061106388.HKD","FTXH","LU1037948897.HKD","BK4139","LU1066051225.USD","LGHT","LU2148510915.USD","IE00BJT1NW94.SGD","HRTS","LU0859254822.USD","IE00B2B36J28.USD","LU2361045086.USD","LU1064130708.USD","IDNA","LU0070302665.USD","RXL","BK4585","LU1430594728.SGD","LU1057294990.SGD","LU1917777945.USD","LU0965509010.AUD","BK4588","LU1093756168.USD","LU0265550359.USD","LU0006306889.USD","LU0122379950.USD","GDOC","LU1116320737.USD","BK4568","LU1069347547.HKD","BK4551","LU0320765646.SGD","LU1699723380.USD","LU2361044949.HKD","SGXZ57979304.SGD","TRUH","JDOC","LU2491050154.USD","300142","BK0196","LU0985320562.USD","LU2106854487.HKD","LU2580892862.HKD","SG9999014567.USD","LU1989772923.USD","LU2491049909.HKD","LU1934455863.HKD","FHLC","LU1116320901.HKD","300122","IE00B4R5TH58.HKD","LU2089984988.USD","MRNX","06185","SG9999014559.SGD","LU0868494708.USD","BK4533","LU1066053197.SGD","LU0823416689.USD","LU0203347892.USD","LU1328615791.USD","LU2357627491.SGD","IXJ","LU0266013472.USD","LU2125154778.USD","LU2125154935.USD","SG9999015358.SGD","LU2433249047.HKD","LU0208291251.USD","SG9999001176.SGD","LU1934455194.USD","WDNA","SG9999002232.USD","SG9999014542.SGD","LU0289739699.SGD","LU1066051811.HKD","LU2324357040.USD","688276","LU1941712264.USD","MRNA","LU0432979614.USD","LU2112291526.USD","LU0980610538.SGD","IE00BBT3K403.USD","PPH","LU0130517989.USD","PAWZ","SG9999001176.USD","BK0239","SG9999013999.USD","LU0477156953.USD","LU1035773651.USD","IE00B1BXHZ80.USD","BK4534","LU1929549753.HKD","LU1093756325.SGD","LU0648001328.SGD","SG9999002224.SGD","BK4548","IE00BSNM7G36.USD","BK4516","GNOM","IHE","LU1162221912.USD","LU1923622614.USD","BK0070","300006","LU1934455277.USD","LU2360032135.SGD","SG9999015341.SGD","IE0002141913.USD","LU0320765489.SGD","LU0203345920.USD","LU0058720904.USD","BK4559","LU0965509101.SGD","BK0188","LU1974910355.USD","LU0265550946.USD","LU2125909247.SGD","LU2580892789.USD","MRNY","LU2468319806.SGD","LU0106261372.USD","LU1983299246.USD","IE00BFTCPJ56.SGD","MRK","SG9999014575.USD","IE00BLSP4452.SGD","IYH","BK0046","BK4532","LU2461242641.AUD","LU0238689110.USD","LU1037948541.HKD","LU1201861249.SGD","IE000M9KFDE8.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658984704","title":"莱美药业(300006)7月31日股东户数2.54万户,较上期增加6.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658984704","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658984704?lang=zh_cn&edition=full","pubTime":"2026-08-10 17:36","pubTimestamp":1786354577,"startTime":"0","endTime":"0","summary":"证券之星消息,近日莱美药业披露,截至2026年7月31日公司股东户数为2.54万户,较7月20日增加1542.0户,增幅为6.47%。在化学制药行业个股中,莱美药业股东户数低于行业平均水平,截至7月31日,化学制药行业平均股东户数为3.59万户。从股价来看,2026年7月20日至2026年7月31日,莱美药业区间涨幅为6.1%,在此期间股东户数增加1542.0户,增幅为6.47%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000022704.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","300006","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658986447","title":"莱美药业(300006.SZ)获得吸入用乙酰半胱氨酸溶液药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2658986447","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658986447?lang=zh_cn&edition=full","pubTime":"2026-08-10 15:56","pubTimestamp":1786348591,"startTime":"0","endTime":"0","summary":"智通财经APP讯,莱美药业(300006.SZ)发布公告,近日,公司收到国家药品监督管理局核准签发的吸入用乙酰半胱氨酸溶液(3ml:0.3g)《药品注册证书》。本次获得吸入用乙酰半胱氨酸溶液的《药品注册证书》,将有利于进一步丰富公司产品线,提升公司竞争力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1477938.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"莱美药业(300006.SZ)获得吸入用乙酰半胱氨酸溶液药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0070","300006"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658865879","title":"莱美药业:截至2026年7月31日,公司股东户数为25,384","url":"https://stock-news.laohu8.com/highlight/detail?id=2658865879","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658865879?lang=zh_cn&edition=full","pubTime":"2026-08-10 15:39","pubTimestamp":1786347554,"startTime":"0","endTime":"0","summary":"证券之星消息,莱美药业(300006)08月10日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止到7月31日公司股东人数是多少?谢谢莱美药业回复:尊敬的投资者,您好。截至2026年7月31日,公司股东户数为25,384。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000014583.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","300006"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654165260","title":"莱美药业(300006)7月20日股东户数2.38万户,较上期减少2.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654165260","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654165260?lang=zh_cn&edition=full","pubTime":"2026-07-27 17:35","pubTimestamp":1785144959,"startTime":"0","endTime":"0","summary":"证券之星消息,近日莱美药业披露,截至2026年7月20日公司股东户数为2.38万户,较7月10日减少629.0户,减幅为2.57%。在化学制药行业个股中,莱美药业股东户数低于行业平均水平,截至7月20日,化学制药行业平均股东户数为3.58万户。从股价来看,2026年7月10日至2026年7月20日,莱美药业区间跌幅为5.36%,在此期间股东户数减少629.0户,减幅为2.57%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072700022889.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","300006"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653872982","title":"莱美药业(300006)披露签署《药品上市许可转让协议》公告,7月23日股价下跌4.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653872982","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653872982?lang=zh_cn&edition=full","pubTime":"2026-07-23 22:33","pubTimestamp":1784817195,"startTime":"0","endTime":"0","summary":"截至2026年7月23日收盘,莱美药业报收于5.03元,较前一交易日下跌4.55%,最新总市值为53.11亿元。近日,重庆莱美药业股份有限公司与江西天之海药业股份有限公司签署《药品上市许可转让协议》,以2800万元受让维生素D软胶囊的药品注册批文及全球范围内的全部商业和市场权益。本次交易不构成关联交易或重大资产重组,无需提交董事会及股东会审议。过渡期内,莱美药业可委托天之海药业生产。药品上市许可持有人变更需经国家药监局审批。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300048211.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","300006"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653748636","title":"莱美药业(300006.SZ)与天之海药业签署关于维生素D₂软胶囊药品上市许可转让协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2653748636","media":"智通财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653748636?lang=zh_cn&edition=full","pubTime":"2026-07-23 16:56","pubTimestamp":1784797003,"startTime":"0","endTime":"0","summary":"智通财经APP讯,莱美药业 发布公告,公司与江西天之海药业股份有限公司于近期签署了《药品上市许可转让协议》。根据该协议,公司以人民币2800万元受让天之海药业持有的维生素D软胶囊的药品注册批文、全球范围内现有的全部商业和市场权益及协议产品涉及的其他全部权益。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1471418.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0070","300006","BK0239","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652257275","title":"股市必读:莱美药业(300006)股东户数2.45万户,较上期减少1.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652257275","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652257275?lang=zh_cn&edition=full","pubTime":"2026-07-20 03:02","pubTimestamp":1784487738,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘,莱美药业报收于4.56元,下跌8.98%,换手率3.37%,成交量35.54万手,成交额1.68亿元。股本股东变化:截至2026年7月10日,莱美药业股东户数为2.45万户,较6月30日减少259.0户,减幅1.05%。交易信息汇总资金流向7月17日主力资金净流入16.7万元;游资资金净流入1149.72万元,占总成交额0.0%;散户资金净流出1166.42万元,占总成交额0.0%。户均持股数量由上期的4.27万股增加至4.31万股,户均持股市值为20.93万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000001438.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","300006"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652404882","title":"莱美药业(300006)7月10日股东户数2.45万户,较上期减少1.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652404882","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652404882?lang=zh_cn&edition=full","pubTime":"2026-07-17 17:48","pubTimestamp":1784281725,"startTime":"0","endTime":"0","summary":"证券之星消息,近日莱美药业披露,截至2026年7月10日公司股东户数为2.45万户,较6月30日减少259.0户,减幅为1.05%。在化学制药行业个股中,莱美药业股东户数低于行业平均水平,截至7月10日,化学制药行业平均股东户数为3.56万户。从股价来看,2026年6月30日至2026年7月10日,莱美药业区间跌幅为5.46%,在此期间股东户数减少259.0户,减幅为1.05%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700032904.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300006","BK0070","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652821471","title":"莱美药业:截至2026年4月30日,公司股东户数为24,889","url":"https://stock-news.laohu8.com/highlight/detail?id=2652821471","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652821471?lang=zh_cn&edition=full","pubTime":"2026-07-17 11:36","pubTimestamp":1784259372,"startTime":"0","endTime":"0","summary":"证券之星消息,莱美药业(300006)07月16日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截至4月30日公司的股东人数是多少?谢谢莱美药业回复:尊敬的投资者,您好。截至2026年4月30日,公司股东户数为24,889。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700017421.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","300006","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651486285","title":"股市必读:莱美药业(300006)股东户数2.47万户,较上期增加3.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651486285","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651486285?lang=zh_cn&edition=full","pubTime":"2026-07-15 03:49","pubTimestamp":1784058549,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘,莱美药业报收于4.74元,上涨1.94%,换手率2.0%,成交量21.1万手,成交额9898.32万元。股本股东变化:截至2026年6月30日,莱美药业股东户数为2.47万户,较6月18日增长3.39%,户均持股由4.41万股降至4.27万股。交易信息汇总资金流向7月14日主力资金净流入142.67万元,占总成交额0.0%;游资资金净流入312.82万元,占总成交额0.0%;散户资金净流出455.48万元,占总成交额0.0%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500005512.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","300006"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651288391","title":"莱美药业:截至2026年6月18日,公司股东户数为23,919","url":"https://stock-news.laohu8.com/highlight/detail?id=2651288391","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651288391?lang=zh_cn&edition=full","pubTime":"2026-07-14 08:33","pubTimestamp":1783989188,"startTime":"0","endTime":"0","summary":"证券之星消息,莱美药业(300006)07月13日在投资者关系平台上答复投资者关心的问题。投资者提问:你好董秘,截止6月25日股东人数是多少?1a2b期纳米碳铁混悬注射液临床中期数据出了吗?联合放疗二期入组人数及进展?莱美药业回复:尊敬的投资者,您好。截至2026年6月18日,公司股东户数为23,919。公司子公司四川瀛瑞的纳米炭铁混悬注射液(CNSI-Fe)联合放疗已正式进入二期临床阶段,四川瀛瑞正积极推进相关工作,确保试验的顺利进行。关于该产品研发进展情况公司将严格按照相关规定履行信息披露义务。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400008300.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300006","BK0070","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651128889","title":"莱美药业:纳米炭铁混悬注射液联合放疗已正式进入二期临床阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2651128889","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651128889?lang=zh_cn&edition=full","pubTime":"2026-07-14 08:30","pubTimestamp":1783989040,"startTime":"0","endTime":"0","summary":"证券之星消息,莱美药业07月13日在投资者关系平台上答复投资者关心的问题。当前受试者随访推进至哪个阶段?公司子公司四川瀛瑞的纳米炭铁混悬注射液联合放疗已正式进入二期临床阶段,四川瀛瑞正积极推进相关工作,确保试验的顺利进行。关于该产品研发进展情况公司将严格按照相关规定履行信息披露义务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400008237.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300006","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651288931","title":"莱美药业:严格控制成本费用,实现可控费用持续下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2651288931","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651288931?lang=zh_cn&edition=full","pubTime":"2026-07-14 08:30","pubTimestamp":1783989039,"startTime":"0","endTime":"0","summary":"证券之星消息,莱美药业07月13日在投资者关系平台上答复投资者关心的问题。投资者提问:公司2025全年亏损、2026年一季度继续亏损,年报、季报提及传统产品受集采降价影响毛利率下滑。同时,严格控制成本费用,制定详细方案从各环节入手降低成本费用,实现可控费用持续下降。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400008236.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","300006"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649284640","title":"莱美药业(300006)6月30日股东户数2.47万户,较上期增加2.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649284640","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649284640?lang=zh_cn&edition=full","pubTime":"2026-07-06 17:36","pubTimestamp":1783330563,"startTime":"0","endTime":"0","summary":"证券之星消息,近日莱美药业披露,截至2026年6月30日公司股东户数为2.47万户,较6月10日增加657.0户,增幅为2.73%。在化学制药行业个股中,莱美药业股东户数低于行业平均水平,截至6月30日,化学制药行业平均股东户数为3.56万户。从股价来看,2026年6月10日至2026年6月30日,莱美药业区间跌幅为0.39%,在此期间股东户数增加657.0户,增幅为2.73%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600024568.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","300006"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648668665","title":"莱美药业(300006)披露产业投资基金拟清算注销公告,7月2日股价下跌3.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648668665","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648668665?lang=zh_cn&edition=full","pubTime":"2026-07-02 22:47","pubTimestamp":1783003634,"startTime":"0","endTime":"0","summary":"截至2026年7月2日收盘,莱美药业报收于4.97元,较前一交易日下跌3.87%,最新总市值为52.48亿元。近日,莱美药业披露《关于投资的产业投资基金拟清算注销的公告》。2026年6月30日,全体合伙人决议合伙期限届满后不再延期,对赛富健康实施清算注销。清算过程中,赛富健康将其持有的海南莱美医疗器械有限公司82.3529%股权以非现金分配方式转让给公司,公司无需支付对价。公司后续将依法推进清算及注销程序,并及时披露进展。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200042453.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","300006"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643831257","title":"股市必读:莱美药业(300006)6月15日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2643831257","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2643831257?lang=zh_cn&edition=full","pubTime":"2026-06-16 03:25","pubTimestamp":1781551511,"startTime":"0","endTime":"0","summary":"截至2026年6月15日收盘,莱美药业报收于5.12元,上涨2.2%,换手率2.5%,成交量26.43万手,成交额1.36亿元。董秘最新回复投资者: 你好董秘,截止2026年6月10日股东人数多少?截至2026年6月10日,公司股东户数为24,073。当日关注点交易信息汇总:6月15日主力资金净流入87.73万元,占总成交额0.0%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600004418.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","300006","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1787286663822,"stockEarnings":[{"period":"1week","weight":0.1061},{"period":"1month","weight":0.3142},{"period":"3month","weight":0.0206},{"period":"6month","weight":0.1647},{"period":"1year","weight":0.1716},{"period":"ytd","weight":0.1556}],"compareEarnings":[{"period":"1week","weight":-0.0059},{"period":"1month","weight":0.0102},{"period":"3month","weight":-0.0509},{"period":"6month","weight":-0.0437},{"period":"1year","weight":0.0365},{"period":"ytd","weight":-0.0164}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"重庆莱美药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"25384人(较上一季度增加6.47%)","perCapita":"41593股","listingDate":"2009-10-30","address":"重庆市南岸区玉马路99号","registeredCapital":"105591万元","survey":" 重庆莱美药业股份有限公司的主营业务是医药制造。公司的主要产品是特色专科类化药(包括抗肿瘤药、消化系统药、肠外营养药)、抗感染类化药。公司2019年被工信部认定为“国家技术创新示范企业”,荣获“新中国成立70年医药产业标杆企业”,2021年被重庆市经信委评为重庆市工业和信息化重点实验室,2022年被国家知识产权局评为“国家知识产权示范企业”,2024年被制造业跃升领导小组办公室评为“制造业跃升发展创新领军企业”,2025年被南岸区重庆经开区制造业高质量发展办公室评为“制造业创新领军企业”,2026年被全联药业商会评为2025-2026年度医药行业自主创新企业。","listedPrice":16.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"莱美药业(300006)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供莱美药业(300006)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"莱美药业,300006,莱美药业股票,莱美药业股票老虎,莱美药业股票老虎国际,莱美药业行情,莱美药业股票行情,莱美药业股价,莱美药业股市,莱美药业股票价格,莱美药业股票交易,莱美药业股票购买,莱美药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"莱美药业(300006)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供莱美药业(300006)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}